FUNDING CANCER - Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development
Sponsor: NIH
Description: This funding opportunity will support rigorous development and validation of digital health technology (DHT) derived biomarkers or clinical outcome assessments (COAs) for remote monitoring to fill a defined, unmet clinical endpoint for interventional clinical trials. Applicants must propose to develop and evaluate DHT enabled biomarkers or COAs in three or more diseases and conduct studies informed by people with lived experience and patient advocacy organizations. The first phase of this funding mechanism will evaluate technical performance, and the second phase will support a longitudinal clinical study.
Applications Due:
- February 21, 2025
- June 20, 2025
- February 20, 2026
- June 22, 2026
To view all current UVACCC funding opportunities, please click here.
For all open cancer-related funding opportunities, please click here.